Costunolide Inhibits Osteoclast Differentiation by Suppressing c‐Fos Transcriptional Activity
Authors:
- 6 July 2013
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 28 (4) , 586-592
Abstract
Costunolide, a sesquiterpene lactone, exhibits anti‐inflammatory and anti‐oxidant properties and mediates apoptosis. However, its effects and mechanism of action in osteoclasts remain unknown. Herein, we found that costunolide significantly inhibited RANKL‐induced BMM differentiation into osteoclasts in a dose‐dependent manner without affecting cytotoxicity. Costunolide did not regulate the early signaling pathways of RANKL, including the mitogen‐activated protein kinase and NF‐κB pathways. However, costunolide suppressed nuclear factor of activated T‐cells, cytoplasmic 1 (NFATc1) expression via inhibition of c‐Fos transcriptional activity without affecting RANKL‐induced c‐Fos expression. The inhibitory effects of costunolide were rescued by overexpression of constitutively active (CA)‐NFATc1. Taken together, our results suggest that costunolide inhibited RANKL‐induced osteoclast differentiation by suppressing RANKL‐mediated c‐Fos transcriptional activity. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
Funding Information
- Korean Health Technology R&D Project. Ministry of Health and Welfare, Republic of Korea (A120152)
This publication has 32 references indexed in Scilit:
- Parthenolide sensitizes hepatocellular carcinoma cells to trail by inducing the expression of death receptors through inhibition of STAT3 activationJournal of Cellular Physiology, 2010
- Wogonin inhibits osteoclast formation induced by lipopolysaccharidePhytotherapy Research, 2010
- Inhibition of osteoclast differentiation and bone resorption by rotenone, through down-regulation of RANKL-induced c-Fos and NFATc1 expressionBone, 2010
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Isodeoxyelephantopin, a Novel Sesquiterpene Lactone, Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis through Suppression of Nuclear Factor-κB (NF-κB) Activation and NF-κB-Regulated Gene ExpressionClinical Cancer Research, 2006
- Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated OsteoclastogenesisJournal of Biological Chemistry, 2005
- Sesquiterpene Lactone Parthenolide Blocks Lipopolysaccharide-Induced Osteolysis Through the Suppression of NF-κB ActivityJournal of Bone and Mineral Research, 2004
- Osteoclast differentiation and activationNature, 2003
- Control of osteoblast function and regulation of bone massNature, 2003
- Active compounds from Saussurea lappa Clarks that suppress hepatitis B virus surface antigen gene expression in human hepatoma cellsAntiviral Research, 1995